| Trial ID: | L0708 |
| Source ID: | NCT00124969
|
| Associated Drug: |
Amlodipine
|
| Title: |
Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Failure, Chronic
|
| Interventions: |
DRUG: Amlodipine|DRUG: Placebo
|
| Outcome Measures: |
Primary: The primary outcome will be the survival rate. The secondary outcome will be cardiovascular events., Prospective: look forward using periodic observations collected predominantly following subject enrollment |
|
| Sponsor/Collaborators: |
Sponsor: Charite University, Berlin, Germany
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
356
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2002-01
|
| Completion Date: |
2006-10
|
| Results First Posted: |
|
| Last Update Posted: |
2008-05-09
|
| Locations: |
Charite Campus Benjamin Franklin, Berlin, 12200, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00124969
|
